Clinical Trials Logo

Clinical Trial Summary

This is a randomized double blind placebo-controlled study that will assess the efficacy of Tamsulosin oral-controlled absorption system (OCAS) 0.4 mg in the conjunctive medical treatment of distal ureteral stones with a size of 4-10 mm compared to placebo in control group.


Clinical Trial Description

- patient will be randomized to receive placebo or Tamsulosin OCAS 0.4 mg 1 tablet OD for a maximum of 28 days or until the ureteral stone is passed and sodium diclofenac 50 mg twice a day, for 10 days.

- All patients will receive 75 mg sodium diclofenac via intramuscular on demand ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01167062
Study type Interventional
Source ChaingMai University
Contact Bannakij Lojanapiwat, M.D.
Phone 66-53-945532
Email blojanap@mail.med.cmu.ac.th
Status Recruiting
Phase Phase 4
Start date June 2010

See also
  Status Clinical Trial Phase
Recruiting NCT05100017 - Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure N/A
Recruiting NCT03692715 - Antibiotic Prophylaxis Before Shock Wave Lithotripsy Phase 4
Recruiting NCT01450566 - Intraureteral Lidocaine for Post-Ureteroscopy Pain N/A
Completed NCT00831701 - Medical Expulsive Therapy of Single Distal Ureteral Stones N/A
Completed NCT00177086 - Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi Phase 3
Completed NCT02577146 - The Predictive Value of Ureteral Jet Assessment With Ultrasound in Patients Presenting With Acute Renal Colic N/A
Completed NCT00517205 - Study on 'The Use of Non-contrast Helical Computerized Tomogram in Predicting Treatment Outcomes of Upper Ureteric Stone by Extracorporeal Shock Wave Lithotripsy Using the Sonolith 4000+ Lithotripter' N/A
Completed NCT06105827 - Clinical Study of Ningmitai Capsule on Promoting the Passage of Residual Fragments After Ureteroscopic Lithotripsy Phase 4
Completed NCT03888144 - Study of Ketorolac Versus Opioid for Pain After Endoscopy Phase 4
Not yet recruiting NCT04606758 - Fluoroscopic Guided vs US-guided Percutaneous Nephrolithotripsy for the Treatment of Stone Disease N/A
Not yet recruiting NCT01008267 - Shockwave Lithotripsy (SWL) Under Selective, General Anesthesia. N/A
Completed NCT04069338 - Comparison of Lithotripsy Urolithiasis Machines N/A
Recruiting NCT04069013 - Standard vs Mini-PCNL for the Treatment of Stone Disease N/A
Withdrawn NCT00304317 - Celecoxib (Celebrex) in the Management of Acute Renal Colic Phase 4
Completed NCT01144949 - Study of Silodosin to Facilitate Passage of Urinary Stones Phase 2
Terminated NCT03614052 - Tamsulosin as Adjuvant Treatment Prior to Endoscopic Ureterolithotomy Phase 4
Completed NCT03344120 - Symptoms Comparison: Suture-stent vs Conventional Double-J Stents After Ureterorenoscopy. A Prospective Randomized Trial N/A
Recruiting NCT05153629 - Noninvasive Electrical Stimulator as a Pain Control Treatment Post-ureteroscopy N/A
Recruiting NCT05739812 - The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery N/A
Completed NCT01542593 - Evaluating Ureteral Length Using Computed Tomography (CT) N/A